A detailed history of Clare Market Investments LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clare Market Investments LLC holds 3,434 shares of EW stock, worth $241,513. This represents 0.06% of its overall portfolio holdings.

Number of Shares
3,434
Holding current value
$241,513
% of portfolio
0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$64.54 - $75.92 $221,630 - $260,709
3,434 New
3,434 $254 Million
Q3 2024

Feb 20, 2025

BUY
$59.7 - $93.78 $41,790 - $65,646
700 Added 25.6%
3,434 $227 Million
Q2 2024

Feb 20, 2025

BUY
$84.3 - $94.31 $10,453 - $11,694
124 Added 4.75%
2,734 $253 Million
Q1 2024

Feb 20, 2025

BUY
$72.54 - $95.56 $189,329 - $249,411
2,610 New
2,610 $249 Million
Q3 2023

Feb 20, 2025

SELL
$69.28 - $93.38 $191,212 - $257,728
-2,760 Closed
0 $0
Q2 2023

Feb 20, 2025

SELL
$81.41 - $94.33 $54,870 - $63,578
-674 Reduced 19.63%
2,760 $260 Million
Q2 2022

Feb 20, 2025

SELL
$86.5 - $128.27 $103,800 - $153,924
-1,200 Reduced 30.3%
2,760 $262 Million
Q1 2022

Feb 20, 2025

SELL
$101.96 - $128.34 $30,587 - $38,502
-300 Reduced 7.04%
3,960 $466 Million
Q1 2021

Feb 20, 2025

SELL
$78.68 - $90.67 $70,812 - $81,603
-900 Reduced 17.44%
4,260 $356 Million
Q2 2020

Feb 20, 2025

BUY
$57.54 - $76.95 $197,937 - $264,708
3,440 Added 200.0%
5,160 $357 Million
Q1 2020

Feb 20, 2025

SELL
$52.41 - $81.0 $89,830 - $138,834
-1,714 Reduced 49.91%
1,720 $324 Million
Q3 2019

Feb 20, 2025

BUY
$61.55 - $75.43 $8,309 - $10,183
135 Added 6.98%
2,070 $455 Million
Q2 2019

Feb 20, 2025

SELL
$55.74 - $64.41 $11,148 - $12,882
-200 Reduced 9.37%
1,935 $357 Million
Q1 2019

Feb 20, 2025

BUY
$47.89 - $64.05 $18,437 - $24,659
385 Added 22.0%
2,135 $408 Million
Q4 2018

Feb 20, 2025

SELL
$46.41 - $56.94 $78,154 - $95,886
-1,684 Reduced 49.04%
1,750 $268 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clare Market Investments LLC Portfolio

Follow Clare Market Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clare Market Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clare Market Investments LLC with notifications on news.